Exploring the power of focused ultrasound in disrupting the blood-brain barrier, Dr. Ahluwalia’s LIBERATE trial is set to revolutionize the treatment landscape for glioblastoma.

Clinicians are eyeing the increased survival odds associated with Tagrisso, a targeted therapy for early-stage NSCLC patients. This revelation may shift the narrative on post-operative treatment protocols, promoting wider acceptance in oncological circles.

Understand the profound implications of Dr. Vidal’s latest research on racial disparities in NGS testing for advanced non-small cell lung cancer, revealing a systemic issue that spans across practices and extends to the level of individual physicians.

Explore the latest findings from the VESPER trial that suggest a promising shift in bladder cancer treatment strategy, potentially setting a new standard for neoadjuvant therapy.

Explore the data-driven insights from the Medscape survey on the shifts in physicians’ happiness levels and lifestyle choices due to pandemic stresses, and discover the keys to maintaining a fulfilling life beyond the hospital doors.

A deeper understanding of the impact of smoking and vaping on cancer survivor symptom burdens might open new avenues for tailoring smoking cessation interventions. Uncover how these findings could challenge common assumptions and transform symptom management strategies in our recent article.